Thomas McCourt - Ironwood Pharmaceuticals Insider

IRWD -- USA Stock  

USD 21.07  0.25  1.20%

Chief Commercial Officer and Sr. VP of Marketing and Sales
Mr. Thomas A. McCourt is Senior Vice President Marketing and Sales, Chief Commercial Officer of the Company. He has served as our senior vice president of marketing and sales and chief commercial officer since joining Ironwood in 2009. Prior to joining Ironwood, Mr. McCourt led the U.S. brand team for denosumab at Amgen Inc. from April 2008 to August 2009. Prior to that, Mr. McCourt was with Novartis AG from 2001 to 2008, where he directed the launch and growth of Zelnorm for the treatment of patients with IBSC and CIC and held a number of senior commercial roles, including vice president of strategic marketing and operations. Mr. McCourt was also part of the founding team at Astra Merck Inc., leading the development of the medical affairs and science liaison group and then serving as brand manager for Prilosec and NEXIUM. Mr. McCourt serves on the board of directors of Acceleron Pharma Inc. and has a degree in pharmacy from the University of Wisconsin.
Age: 58  SVP Since 2009      
617-621-7722  http://www.ironwoodpharma.com

Thomas McCourt Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (10.13) % which means that it has lost $10.13 on every $100 spent on asset. This is way below average.
The company currently holds 403.69 M in liabilities. Ironwood Pharmaceuticals has Current Ratio of 4.33 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 3 records

SVP Since

Sherry KorczynskiEagle Pharmaceuticals
N/A
John MaslowskiFibrocell Science
2017
Judy JoiceDURECT Corporation
2014

Entity Summary

Ironwood Pharmaceuticals, Inc., a commercial biotechnology company, engages in the research, development, and commercialization of human therapeutic products. Ironwood Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts. Ironwood Pharmaceuticals operates under Drug Manufacturers - Specialty Generic classification in USA and traded on NASDAQ. It employs 730 people.Ironwood Pharmaceuticals (IRWD) is traded on BATS Exchange in USA. It is located in MASSACHUSETTS U.S.A and employs 730 people. Ironwood Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

Ironwood Pharmaceuticals Leadership Team

Terrance McGuire, Director, MBA
Meredith Kaya, Director
Julie McHugh, Director
Christopher Wright, President
Christopher Walsh, Director, Ph.D
Thomas McCourt, SVP
Lawrence Olanoff, Director, Ph.D
Marsha Fanucci, Director, MBA
Halley Gilbert, President
Peter Hecht, CEO
Andrew Dreyfus, Director
Douglas Williams, Director
William Huyett, COO, MBA
Mark Currie, President, Ph.D
Gina Consylman, CFO
Edward Owens, Director, MBA
Thomas Graney, CFO, MBA
Amy Schulman, Director
Bryan Roberts, Chairman, Ph.D
George Conrades, Director, MBA

Stock Performance Indicators

Did you try this?

Run Fund Screener Now
   

Fund Screener

Find activelly-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Fund Screener

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.